|
Market Closed -
Nasdaq
16:00:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 306.77 USD | +1.26% |
|
-2.33% | +62.25% |
| 09-25 | Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target | MT |
| 09-24 | Ligand Pharmaceuticals Invests Up to $47 Million in AvenCell | MT |
Stock exchange
Nasdaq
LGND 306.77 $
+1.26%
50.26M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LGND | 306.77USD | +1.26% | 50.26M $ | ||
CBOE
| LGND | 306.80USD | +1.06% | 1.28M $ | |
|
Deutsche Boerse AG
| LGDN | 270.00EUR | +2.27% | 0 € | |
|
Tradegate
| LGDN | 274.00EUR | +1.48% | 0 € | |
|
Börse Stuttgart
| LGDN | 272.00EUR | 0.00% | 0 € | |
|
Boerse Muenchen
| LGDN | 272.00EUR | 0.00% | 0 € | |
|
Berne S.E.
| LGDN | 253.73CHF | +0.34% | 0 CHF |
Quotes 5-day view: Ligand Pharmaceuticals Incorporated
Delayed Quote Nasdaq
| 2026-09-29 | 2026-09-30 | 2026-10-01 | 2026-10-02 | 2026-10-05 | |
|---|---|---|---|---|---|
| Last | US$310.36 | US$312.37 | US$302.74 | US$302.96 | US$306.77 |
| Volume | 430,961 | 505,862 | 374,019 | 179,228 | 163,820 |
| Change | -1.19% | +0.65% | -3.08% | +0.07% | +1.26% |
| Opening | US$313.63 | US$310.52 | US$309.82 | US$307.55 | US$303.95 |
| High | US$317.10 | US$317.23 | US$312.05 | US$307.63 | US$309.77 |
| Low | US$304.36 | US$306.95 | US$301.48 | US$301.32 | US$300.79 |
Performance
| 1 day | +1.26% | ||
| 1 week | -2.33% | ||
| Current month | -1.79% | ||
| 1 month | +7.41% | ||
| 3 months | -4.00% | ||
| 6 months | +53.70% | ||
| Current year | +62.25% | ||
| 1 year | +69.50% | ||
| 3 years | +427.82% | ||
| 5 years | +138.03% | ||
| 10 years | +202.89% |
Volumes
marketsDaily volume
163,820
Estimated daily volume
163,820
Avg. Volume 20 sessions
286,399
Daily volume ratio
0.57
Avg. Volume 20 sessions USD
87,858,621.23
Record volume 1
8,575,945
Record volume 2
5,579,534
Record volume 3
4,904,028
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
6,115,646,772
Net sales (USD)
268,087,000
Number of employees
47
Sales / Employee (USD)
5,703,979
Free-Float
97.66%
Free-Float capitalization (USD)
5,972,336,099
Average Daily Capital Traded
1.44%
Indicators
Moving average 5 days
307.04
Moving average 20 days
293.36
Moving average 50 days
291.74
Moving average 100 days
280.19
Price spread / (MMA5)
+0.09%
Price spread / (MMA20)
-4.37%
Price spread / (MMA50)
-4.90%
Price spread / (MMA100)
-8.66%
STIM
RSI 9 days
57.11
RSI 14 days
57.14
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.26% | -2.33% | +69.50% | +427.82% | 6.12B | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.08% | +60.96% | 610B | |
| +1.12% | -0.20% | +13.62% | +80.24% | 470B | |
| -3.30% | -6.15% | +56.45% | +34.69% | 344B | |
| +1.20% | +1.26% | +22.64% | +42.56% | 336B | |
| +1.20% | -2.45% | +11.49% | +33.47% | 266B | |
| +1.98% | -3.56% | -5.81% | +9.54% | 241B | |
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | |
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | |
| Average | +0.75% | -3.50% | +30.17% | +94.60% | 368.89B | |
| Weighted average by Cap. | +0.75% | -3.50% | +28.69% | +69.46% |
Historical Quotes: Ligand Pharmaceuticals Incorporated
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6836ad81.Z8EUEfuheFcwff6VAqS4KWLy2oPGHs6EcYAd8EbPkF0.LodMJ735LwEGML3GZ_HKQyq3jcCzZv_gFa1NsgP31xAhomx6v81AH1c7mQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 306.77 | 55,875 | 89,245 |
| 16:00:00 | 307.23 | 100 | 33,370 |
| 15:59:59 | 307.23 | 100 | 33,270 |
| 15:59:59 | 307.23 | 100 | 33,170 |
| 15:59:59 | 307.09 | 100 | 33,070 |
| 15:59:59 | 307.09 | 100 | 32,970 |
| 15:59:59 | 307.09 | 100 | 32,870 |
| 15:59:59 | 307.09 | 100 | 32,770 |
| 15:59:59 | 307.10 | 100 | 32,670 |
| 15:59:58 | 306.95 | 100 | 32,570 |
Price Extremes
| 1 week | 300.79 |  | 317.23 |
| 1 month | 270.77 | | 317.23 |
| Current year | 175.89 | | 326.63 |
| 1 year | 175.89 | | 326.63 |
| 3 years | 49.24 | | 326.63 |
| 5 years | 49.24 | | 326.63 |
| 10 years | 49.24 | | 326.63 |
Monthly variations
Annual variations
| 2026 | +62.25% | ||
| 2025 | +76.45% | ||
| 2024 | +50.03% | ||
| 2023 | +6.92% | ||
| 2022 | -56.75% | ||
| 2021 | +55.31% | ||
| 2020 | -4.64% | ||
| 2019 | -23.15% | ||
| 2018 | -0.90% | ||
| 2017 | +34.76% | ||
| 2016 | -6.28% | ||
| 2015 | +103.76% | ||
| 2014 | +1.16% | ||
| 2013 | +153.62% | ||
| 2012 | +74.73% | ||
| 2011 | +33.07% | ||
| 2010 | -31.49% | ||
| 2009 | -20.80% | ||
| 2008 | -43.27% | ||
| 2007 | -55.89% | ||
| 2006 | -1.79% | ||
| 2005 | -4.21% | ||
| 2004 | -20.76% | ||
| 2003 | +173.56% | ||
| 2002 | -70.00% | ||
| 2001 | +27.86% | ||
| 2000 | +8.74% | ||
| 1999 | +10.75% | ||
| 1998 | -9.71% | ||
| 1997 | -13.45% | ||
| 1996 | +38.37% | ||
| 1995 | +30.30% | ||
| 1994 | -17.50% |
- Stock Market
- Stocks
- LGND Stock
- Quotes Ligand Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
